Loading insider details...
Beta
Latest Form 4 (May 14, 2026): Grant/Award of 10,958 ANRO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| May 14, 2026 | Alto Neuroscience, Inc. (ANRO) | Grant/Award | 10,958 | n/a |
| Jun 12, 2025 | IRONWOOD PHARMACEUTICALS INC (IRWD) | Grant/Award | 45,000 | n/a |
| May 15, 2025 | Alto Neuroscience, Inc. (ANRO) | Grant/Award | 15,287 | n/a |
| Jun 21, 2024 | IRONWOOD PHARMACEUTICALS INC (IRWD) | Grant/Award | 24,311 | n/a |
| Feb 5, 2024 | Alto Neuroscience, Inc. (ANRO) | Grant/Award | 30,574 | n/a |
| Jun 22, 2023 | IRONWOOD PHARMACEUTICALS INC (IRWD) | Grant/Award | 22,350 | n/a |
| Jun 3, 2022 | IRONWOOD PHARMACEUTICALS INC (IRWD) | Grant/Award | 21,571 | n/a |
| Dec 17, 2021 | IRONWOOD PHARMACEUTICALS INC (IRWD) | Grant/Award | 1,431 | n/a |
| Sep 17, 2021 | IRONWOOD PHARMACEUTICALS INC (IRWD) | Grant/Award | 1,344 | n/a |
| Jun 16, 2021 | IRONWOOD PHARMACEUTICALS INC (IRWD) | Grant/Award | 1,453 | n/a |